Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia

REFERENCES

• Bruce R D, Altice F L, Friedland G H. HIV disease among substance users: Treatment issues. Global HIV/AIDS medicine, P. Volberding. Elsevier, New York 2007
   Google Scholar
• Bruce R D, Altice F L. Clinical care of the HIV-infected drug user. Infect Dis Clin North Am 2007; 2(1)149–179; ix
   Web of Science ®Google Scholar
• Loo H W, Yam A K, Tan T C, Peng Y, Teoh L C. Severe upper limb complications from parenteral abuse of Subutex. Ann Acad Med Singapore 2005; 3(9)575–578
   Google Scholar
• Lai S H, Teo C E. Buprenorphine-associated deaths in Singapore. Ann Acad Med Singapore 2006; 35(7)508–511
   PubMed Web of Science ®Google Scholar
• Lee C E. Tackling Subutex abuse in Singapore. Singapore Med J 2006; 4(11)919–921
   Google Scholar
• Lo H Y, Leong C S. Surgical complications in parenteral Subutex abusers. Singapore Med J 2006; 47(11)924–927
   PubMedGoogle Scholar
• Chua S M, Lee T S. Abuse of prescription buprenorphine, regulatory controls and the role of the primary physician. Ann Acad Med Singapore 2006; 3(7)492–495
   Google Scholar
• Winslow M, Subramaniam M, Ng W L, Lee A, Song G, Chan Y H. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in S, ingapore. Singapore Med J 2007; 48(6)504–508
   PubMedGoogle Scholar
• Winslow M, Ng W L, Mythily S, Song G, Yiong H C. Socio-demographic profile and help-seeking behaviour of buprenorphine abusers in Singapore. Ann Acad Med Singapore 2006; 35(7)451–456
   PubMed Web of Science ®Google Scholar
• Ng W L, Mythily S, Song G, Chan Y H, Winslow M. Concomitant ue of midazolam and buprenorphine and its implications among drug users in Singapore. Ann Acad Med Singapore 2007; 36(9)774–777
   PubMed Web of Science ®Google Scholar
• Auriacombe M, Fatseas M, Dubernet J, Daulouede J P, Tignol J. French field experience with buprenorphine. Am J Addic 2004; 13(Suppl 1)S17–S28
   PubMed Web of Science ®Google Scholar
• Jenkinson R A, Clark N C, Fry C L, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia:An emerging issue?. Addiction 2005; 100(2)197–205
   PubMed Web of Science ®Google Scholar
• Willems J C, Iguchi M Y, Lidz V, Bux D A, Jr. Change in drug-using networks of injecting drug users during methadone treatment:A pilot study using snowball recruitment and intensive interviews. Subst.Use Misuse 1997; 32(11)1539–1554
   PubMed Web of Science ®Google Scholar
• Musto D F. The American disease: Origins of narcotic control, third ed. Oxford University Press, New York 1999
   Google Scholar
• Mendelson J, Upton R A, Everhart E T, Jacob P, 3rd, Jones R T. Bioavailability of sublingual buprenorphine. J Clin Pharmacol 1997; 37(1)31–37
   PubMed Web of Science ®Google Scholar
• Harris D S, Jones R T, Welm S, Upton R A, Lin E, Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug Alcohol Depend 2000; 61(1)85–94
   PubMed Web of Science ®Google Scholar
• Cone E J, Gorodetzky C W, Yousefnejad D, Buchwald W F, Johnson R E. The metabolism and excretion of buprenorphine in humans. Drug MetabolDisposition 1984; 12(5)577–581
   PubMed Web of Science ®Google Scholar
• Forsyth A J, Farquhar D, Gemmell M, Shewan D, Davies J B. The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland). Drug Alcohol Depend 1993; 32(3)277–280
   PubMed Web of Science ®Google Scholar
• Lai S H, Yao Y J, Lo D S. A survey of buprenorphine related deaths in Singapore. Foren Scintern 2006; 162(1–3)80–86
   Google Scholar
• Singh R A, Mattoo S K, Malhotra A, Varma V K. Cases of buprenorphine abuse in India. Acta Psychiatrica Scanda 1992; 86(1)46–48
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Mitchell T B, Bond A, Nesto L, Strang J. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J Clin Psychopharmacology 2006; 26(3)274–283
   PubMed Web of Science ®Google Scholar
• Debruyne D, Quentin T, Poisnel G, Lelong-Boulouard V, Barre L, Coquere A. Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain. Brain Res 2005; 1052(2)222–231
   PubMed Web of Science ®Google Scholar
• Pentikainen P J, Valisalmi L, Himberg J J, Crevoisier C. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 1989; 29(3)272–277
   PubMed Web of Science ®Google Scholar
• Wandel C, Bocker R, Bohrer H, Browne A, Rugheimer E, Martin E. Midazolam is metabolized by at least three different cytochrome P450 enzymes. Br J Anaesthesia 1994; 7(5)658–661
   Web of Science ®Google Scholar
• Chang Y, Moody D E. Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes. Eur J Clin Pharmacol 2005; 6(12)875–881
   Web of Science ®Google Scholar